1)Sickle Cell Anaemia :-
A group of disorders that cause red blood cells to become misshapen and break down.With sickle cell disease, an inherited group of disorders, red blood cells contort into a sickle shape. The cells die early, leaving a shortage of healthy red blood cells (sickle cell anaemia) and can block blood flow causing pain (sickle cell crisis).
The Economist Intelligence Unit (EIU) – Novartis report ‘Stepping out of the shadows – Combating Sickle Cell Disease in India’ was also released.
2)Aryabhatta Research Institute of Observational Sciences (ARIES), Nainital, an autonomous institute of the Department of Science & Technology (DST), Govt. of India has organised a special lecture on ‘The Science of Solar Eclipses’.
A solar eclipse occurs when the moon (at the new moon phase) blocks the solar disk partially or completely, leading to a partial, annular, and total solar eclipse, respectively. During the eclipse, the shadow of the moon falls on Earth and constitutes a darker region known as umbra and relatively less dark region, penumbra. Total solar eclipses are the rarest of the solar eclipses. Even though we have a new moon every month, we do not witness eclipses so often. This is due to the fact that the orbit of the moon is inclined at an angle of around 5˚ with respect to the Earth-Sun plane. This leads to the alignment of the Sun, Moon, and Earth as a rare astronomical phenomenon.
3)SVANIDHI Scheme :- A Memorandum of Understanding has been signed between Ministry of Housing & Urban Affairs and Small Industries Development Bank of India (SIDBI,. in order to engage SIDBI as the Implementation Agency for PM Street Vendor’s AtmaNirbhar Nidhi (PM SVANidhi) – a Special Micro-Credit Facility for Street Vendors.
4)Umifenovir:- CSIR constituent lab CSIR-Central Drug Research Institute(CDRI) Lucknow, has received permission for carrying out Phase III randomised, Double blind, Placebo controlled trial of efficacy, safety and tolerability of antiviral drug Umifenovir.
Umifenovir is mainly used for treatment of influenza and is available in China and Russia, and has recently come into prominence due to its potential use for Covid19 patients.
5)India’s First I-Lab :- The Minister for Science & Technology, Earth Sciences and Health & Family Welfare Dr Harsh Vardhan inaugurated and flagged off India’s first I-Lab (Infectious disease diagnostic lab) for Covid testing in rural and inaccessible areas of India.
INFECTIOUS DISEASE DIAGNOSTIC LABORATORY (I-LAB)
- To promote last mile access of testing to rural India, DBT under the Covid-Command strategy has supported building of mobile testing labs through AMTZ.
- The unique feature of these mobile testing labs is their utility in diagnosing other infectious diseases beyond the Covid period
The Department of Biotechnology (DBT), Ministry of Science & Technology along with Andhra Pradesh Med-tech Zone (AMTZ) has initiated the DBT-AMTZ COMManD [COVID Medtech Manufacturing Development] Consortia to address the shortage of critical healthcare technologies in India and move progressively towards a stage of self-sufficiency.
Under this Consortia, India’s first I- lab (infectious disease diagnostic lab) has been buil at AMTZ from Bharat Benz. This is a mobile diagnostic unit with biosafety facility. The I- lab is a BSL-2 facility with on-site ELISA, RT-PCR, Bio chemistry analysers. It can run 50 RT-PCR reactions and about 200 ELISA in a day.Double set of Machines can help increase the capacity to about 500 per day in 8 hours shift.
7)PM Modi to launch Garib Kalyan Rojgar Abhiyaan on 20th June to boost livelihood opportunities in Rural India:- Government of India has decided to launch a massive rural public works scheme ‘Garib Kalyan Rojgar Abhiyaan’to empower and provide livelihood opportunities to the returnee migrant workers and rural citizens.
The Abhiyaan will be launched from Village – Telihar, Block- Beldaur of Khagaria District of Bihar.
This campaign of 125 days, which will work in mission mode, will involve intensified and focused implementation of 25 different types of works to provide employment to the migrant workers on one hand and create infrastructure in the rural regions of the country on the other hand, with a resource envelope of Rs. 50,000 crore.